Ignite Creation Date:
2024-05-06 @ 7:40 AM
Last Modification Date:
2024-10-26 @ 11:51 AM
Study NCT ID:
NCT02579915
Status:
COMPLETED
Last Update Posted:
2020-02-07
First Post:
2015-10-16
Brief Title:
Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders AIM-PC
Sponsor:
Brown University
Organization:
Brown University
Study Overview
Official Title:
Phase 2 Randomized Controlled Trial of Attention and Interpretation Modification AIM for Anxiety Disorders in Primary Care
Status:
COMPLETED
Status Verified Date:
2020-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to develop a personalized user-friendly computerized treatment for anxiety disorders linked to primary care The computerized treatment is a type of Cognitive Bias Modification which targets attention and interpretation biases known to maintain anxiety disorders
Detailed Description:
The primary goals of our 3-year 2-phase project are to develop AIM for primary care linkage and assess its feasibility and acceptability This protocol description only pertains to Phase 2 Randomized Controlled Trial
42 primary care patients with primary Generalized Anxiety Disorder Social Anxiety Disorder andor Panic Disorder with or without Agoraphobia will be randomly assigned to the AIM treatment or to a symptom tracking control group Full assessments will occur pre- and post-treatment and 3-months follow-up A mid-treatment assessment will include measures of cognitive biases and the primary outcome Weekly measures of anxiety and depression will be collected as will feedback from patients and PCPs about the research and delivery procedures
42 primary care patients with primary Generalized Anxiety Disorder Social Anxiety Disorder andor Panic Disorder with or without Agoraphobia will be randomly assigned to the AIM treatment or to a symptom tracking control group Full assessments will occur pre- and post-treatment and 3-months follow-up A mid-treatment assessment will include measures of cognitive biases and the primary outcome Weekly measures of anxiety and depression will be collected as will feedback from patients and PCPs about the research and delivery procedures
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 1R34MH097820-01A1 | NIH | None | httpsreporternihgovquickSearch1R34MH097820-01A1 |